Balanced news tone
News Sentiment
ABVX sentiment intelligence
ABIVAX Société Anonyme news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
90/100 classification confidence.
directly relevant articles
high-authority source matches
-9.0% over one week, +44.5% over four weeks, trend inactive, and materially above fair value.
Abivax: Obefazimod Goes The Distance And So Does My Buy Rating (NASDAQ:ABVX)
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Abivax: Obefazimod Goes The Distance And So Does My Buy Rating (NASDAQ:ABVX)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 16 Jul 2026 14:25
- Source
- Seeking Alpha
Diversify Wealth Management LLC Purchases 14,626 Shares of Abivax SA Sponsored ADR $ABVX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 07:52
- Source
- MarketBeat
Candriam S.C.A. Takes $4.01 Million Position in Abivax SA Sponsored ADR $ABVX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 07:50
- Source
- MarketBeat
Precision Trading with Abivax Sa (ABVX) Risk Zones
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 12 Jul 2026 08:46
- Source
- Stock Traders Daily
Abivax: Wall Street Catches Up to the Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Market source
Is ABIVAX Société Anonyme (ABVX) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Market source
ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Abivax raises $800M as dilution hits 8% and cash reaches 2029
- Tone
- Positive 66/100
- Event
- Balance sheet
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Abivax stock jumps on positive Phase 3 ulcerative colitis data (ABVX:NASDAQ)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Seeking Alpha
Stocks making the biggest moves midday: AeroVironment, Abivax, Astera Labs, Watts Water Technologies & more
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- CNBC
ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 23:57
- Source
- Stocktwits
Abivax: Safety Signals Loom Ahead Of The NDA Submission
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Seeking Alpha
Abivax (ABVX) Jumps 16% on Bargain-Hunting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Market source
Abivax Shares Tumble Despite Strong Ulcerative Colitis Trial Results as Safety Concerns Emerge (ABVX)
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 02 Jun 2026 07:00
- Source
- Market source
What Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Market source
Assessing ABIVAX Société Anonyme (ENXTPA:ABVX) Valuation After Recent Share Price Softness And Conflicting Metrics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Market source
2 Reasons Abivax Stock Could 10X by 2036
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Feb 2026 08:00
- Source
- The Globe and Mail
ABIVAX Societe Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- Finviz
JPM26: Eli Lilly reportedly eyes €15bn takeover of Abivax
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jan 2026 08:00
- Source
- Market source
ABIVAX Société Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jan 2026 08:00
- Source
- Market source
Why Abivax Stock Was on Fire Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Dec 2025 08:00
- Source
- The Motley Fool
Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jul 2025 07:00
- Source
- Seeking Alpha